← All drugs Report issue

balamapimod

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Dual specificity mitogen-activated protein kinase kinase 2INHIBITOR
MAP2K2 inhibitor
No references found
- Dual specificity mitogen-activated protein kinase kinase 2 (MAP2K2) ↗
Dual specificity mitogen-activated protein kinase kinase 1INHIBITOR
MAP2K1 inhibitor
No references found
- Dual specificity mitogen-activated protein kinase kinase 1 (MAP2K1) ↗

Chemistry & pharmacology

Loading structure…

SMILES

COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1N1CCC(N2CCCC2)CC1

Mol. weight: 574.15 g/mol
Lipinski Ro5: 2 violation(s)
Rule of 3: No
Chirality: Achiral Molecule
Inorganic: No
Polymer: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL2104954 ↗

Also known as

balamapimod
balamapimod
mki-833
mki-833